From: A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder
Number | Age (years) | Clinical symptoms | PSA (ng/ml) | DRE | Cytology2 | Gleason score | Clinical staging | Treatment | Follow-up duration (months)/outcome |
---|---|---|---|---|---|---|---|---|---|
1 | 54 | dysuria, frequent micturition (1 month) | 11.5 | III° enlargement, hard palpable lumps (right) | + | 8 | T4N1M1b | TURP surgical castration | 22/death |
2 | 72 | frequent/urgent micturition (3 months) | 19.9 | II° enlargement, hard, no palpable lump | + | 7 | T4N1M1b | surgical castration | 56/death |
3 | 75 | dysuria, frequent micturition (2 years) hematuria (1 month) | 55.0 | III° enlargement, soft, palpable lump (right) | - | 8 | T4N1M1b | TURP surgical castration | 39/death |
4 | 74 | intermittent painless gross hematuria (6 years) | 150.0 | II° enlargement, hard, palpable lump (left) | - | 7 | T4N0M0 | endocrine therapy chemotherapy | 50/survival |
51 | 68 | dysuria, frequent/urgent micturition (2 months) | 31.7 | III° enlargement, soft, no palpable lump | - | - | T4N0M0 | TURP surgical castration | 23/death |
6 | 70 | dysuria, frequent micturition (3 years) hematuria (1 week) | 38.9 | II° enlargement, hard, palpable lump (right) | + | 7 | T4N1M1b | surgical castration | 40/death |
7 | 58 | dysuria, frequent micturition (1 month) | 40.5 | III° enlargement, hard, no palpable lump | - | 7 | T4N0M0 | TURP surgical castration | 30/survival |
8 | 77 | frequent/urgent micturition, (1 year) | 30.5 | III° enlargement, soft, no touchable lump | - | 8 | T4N1M1b | TURP surgical castration | loss to follow-up |
9 | 69 | dysuria frequent/painful micturition (1 year) | 29.9 | II° enlargement, hard, no palpable lump | - | 7 | T4N1M1b | surgical castration anti-androgen drug | 47/survival |
10 | 78 | frequent/urgent micturition (1 year) | 75.0 | II° enlargement, soft, no touchable lump | - | 7 | T4N0M0 | surgical castration | loss to follow-up |
111 | 80 | dysuria, frequent urination (3 years), hematuria (4 days) | 13.5 | III° enlargement soft no palpable lump | - | - | T4N0M0 | TURP endocrine therapy | 21/survival |
12 | 71 | dysuria, frequent/urgent micturition (6 months) | 27.0 | III° enlargement, hard, palpable lump (right) | + | 8 | T4N0M0 | TURP surgical castration | loss to follow-up |
13 | 76 | intermittent, painless, gross hematuria (1 month) | 110.3 | IV° enlargement, hard, no palpable lump | + | 8 | T4N0M0 | TURP endocrine therapy | 16/survival |
14 | 66 | dysuria, frequent/urgent micturition (6 months) | 160.0 | IV° enlargement, hard, no palpable lump | - | 9 | T4N0M0 | TURP endocrine therapy | 12/survival |